Since its first reported use for the treatment of burns victims, acellular dermal matrix (ADM) use has expanded to surgeries including repairing thoracic and abdominal wall defects, and breast reconstruction. FlexHD ® is a brand of ADM prepared from human cadaveric dermis that has been processed to remove antigenic components and is used to reinforce the subpectoral pocket created during submuscular breast implant surgery. Recent documentation of a phenomenon termed 'red breast syndrome' (RBS) has emerged in the medical literature, with little known about its aetiology and treatment. This paper presents a case of blistering cutaneous erythema from FlexHD ® ADM, reviews the current literature on RBS and proposes a treatment methodology.
Introduction
FlexHD ® acellular dermal matrix (ADM) is a tissue matrix derived from human dermis that has been processed to remove cellular components that may trigger an immune or inflammatory response. 1, 2 It is one of many types of ADM present on the market, others being derived from porcine dermis or bovine tissue. 2 It is poorly understood but is associated with the use of ADM in breast reconstruction, presenting as cutaneous erythema over the breast without systemic signs of infection. We present a case of RBS in a patient who had FlexHD ® inserted, presenting with cutaneous erythema, but with associated blistering, and review the current literature on this phenomenon.
Case report
A 43-year-old woman presents with a self-detected right breast lump. The patient has previously had knee surgery, is a non-smoker, and has given birth to two children. She currently works as a physical education teacher, and is otherwise fit and healthy.
Core biopsies of right breast tissue prior to surgery confirmed grade I invasive ductal carcinoma, oestrogen and progesterone receptor positive and HER 2 negative. The patient underwent a skin sparing right mastectomy, right axillary node dissection and tissue expander (TE) insertion with FlexHD ® . A submuscular approach to TE insertion was performed underneath pectoralis major and serratus fascia with a 6 cm x 16 cm sheet of pliable FlexHD ® used to cover the exposed lower pole of the TE, sutured on the superior aspect to pectoralis major and inferiorly to the level of inframammary fold using Vicryl, with two drain tubes inserted. The patient was administered perioperative cefazolin antibiotic which continued during her admission.
The drain tubes were removed on the third postoperative day, and the patient was discharged home with cephalexin.
On day seven post operation, the patient noted warmth, erythema (Figure 1 
